Xerese

Product NDC: 0187-5104
11-digit product format: 001875104
Labeler code: 0187
Product ID: 0187-5104_a4efb63c-e7bf-43da-bbfe-463f672cb1bc
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Acyclovir and Hydrocortisone
Dosage form: CREAM
Route: TOPICAL
Labeler: Bausch Health US LLC
Application: NDA022436
Marketing category: NDA
Marketing start: 2009-07-31
Substance: ACYCLOVIR; HYDROCORTISONE
Active strength: 50; 10 mg/g; mg/g
Pharmacologic classes: Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	0187-5104	0187-5104-02	D	Discontinued by firm		2026-08-03

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 12 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Product NDC	Package NDC	Code	Status	Archive	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0187-5104	0187-5104-02	D	Discontinued by firm	excluded / ndc_excluded.zip	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0187-5104	0187-5104-02	D	Discontinued by firm	excluded / ndc_excluded.zip	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0187-5104	0187-5104-02	D	Discontinued by firm	excluded / ndc_excluded.zip	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0187-5104	0187-5104-02	D	Discontinued by firm	excluded / ndc_excluded.zip	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0187-5104	0187-5104-02	D	Discontinued by firm	excluded / ndc_excluded.zip	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0187-5104	0187-5104-02	D	Discontinued by firm	excluded / ndc_excluded.zip	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0187-5104	0187-5104-02	D	Discontinued by firm	excluded / ndc_excluded.zip	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0187-5104	0187-5104-02	D	Discontinued by firm	excluded / ndc_excluded.zip	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0187-5104	0187-5104-02	D	Discontinued by firm	excluded / ndc_excluded.zip	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0187-5104	0187-5104-02	D	Discontinued by firm	excluded / ndc_excluded.zip	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	0187-5104	0187-5104-02	D	Discontinued by firm	excluded / ndc_excluded.zip	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	0187-5104	0187-5104-02	D	Discontinued by firm	excluded / ndc_excluded.zip	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N022436-001	XERESE	ACYCLOVIR; HYDROCORTISONE	5%;1%	CREAM / TOPICAL		RLD, RS	2009-07-31

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N022436-001	XERESE	5%;1%	CREAM / TOPICAL	RLD, RS	2009-07-31	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022436-001	XERESE	5%;1%	CREAM / TOPICAL	RLD, RS	2009-07-31	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N022436-001	XERESE	5%;1%	CREAM / TOPICAL	RLD, RS	2009-07-31	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022436-001	XERESE	5%;1%	CREAM / TOPICAL	RLD, RS	2009-07-31	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N022436-001	XERESE	5%;1%	CREAM / TOPICAL	RLD, RS	2009-07-31	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N022436-001	XERESE	5%;1%	CREAM / TOPICAL	RLD, RS	2009-07-31	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N022436-001	XERESE	5%;1%	CREAM / TOPICAL	RLD, RS	2009-07-31	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N022436-001	XERESE	5%;1%	CREAM / TOPICAL	RLD, RS	2009-07-31	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N022436-001	XERESE	5%;1%	CREAM / TOPICAL	RLD, RS	2009-07-31	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N022436-001	XERESE	5%;1%	CREAM / TOPICAL	RLD, RS	2009-07-31	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N022436-001	XERESE	5%;1%	CREAM / TOPICAL	RLD, RS	2009-07-31	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N022436-001	XERESE	5%;1%	CREAM / TOPICAL	RLD, RS	2009-07-31	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N022436-001	XERESE	5%;1%	CREAM / TOPICAL	RLD, RS	2009-07-31	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N022436-001	XERESE	5%;1%	CREAM / TOPICAL	RLD, RS	2009-07-31	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N022436-001	XERESE	5%;1%	CREAM / TOPICAL	RLD, RS	2009-07-31	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N022436-001	XERESE	5%;1%	CREAM / TOPICAL	RLD, RS	2009-07-31	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N022436-001	XERESE	5%;1%	CREAM / TOPICAL	RLD, RS	2009-07-31	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N022436-001	XERESE	5%;1%	CREAM / TOPICAL	RLD, RS	2009-07-31	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N022436-001	XERESE	5%;1%	CREAM / TOPICAL	RLD, RS	2009-07-31	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N022436-001	XERESE	5%;1%	CREAM / TOPICAL	RLD, RS	2009-07-31	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N022436-001	XERESE	5%;1%	CREAM / TOPICAL	RLD, RS	2009-07-31	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N022436-001	XERESE	5%;1%	CREAM / TOPICAL	RLD, RS	2009-07-31	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N022436-001	XERESE	5%;1%	CREAM / TOPICAL	RLD, RS	2009-07-31	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N022436-001	XERESE	5%;1%	CREAM / TOPICAL	RLD, RS	2009-07-31	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N022436-001	XERESE	5%;1%	CREAM / TOPICAL	RLD, RS	2009-07-31	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N022436-001	XERESE	5%;1%	CREAM / TOPICAL	RLD, RS	2009-07-31	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N022436-001	XERESE	5%;1%	CREAM / TOPICAL	RLD, RS	2009-07-31	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N022436-001	XERESE	5%;1%	CREAM / TOPICAL	RLD, RS	2009-07-31	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N022436-001	XERESE	5%;1%	CREAM / TOPICAL	RLD, RS	2009-07-31	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N022436-001	XERESE	5%;1%	CREAM / TOPICAL	RLD, RS	2009-07-31	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N022436-001	XERESE	5%;1%	CREAM / TOPICAL	RLD, RS	2009-07-31	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N022436-001	XERESE	5%;1%	CREAM / TOPICAL	RLD, RS	2009-07-31	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N022436-001	XERESE	5%;1%	CREAM / TOPICAL	RLD, RS	2009-07-31	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N022436-001	XERESE	5%;1%	CREAM / TOPICAL	RLD, RS	2009-07-31	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N022436-001	XERESE	5%;1%	CREAM / TOPICAL	RLD, RS	2009-07-31	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N022436-001	XERESE	5%;1%	CREAM / TOPICAL	RLD, RS	2009-07-31	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N022436-001	XERESE	5%;1%	CREAM / TOPICAL	RLD, RS	2009-07-31	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N022436-001	XERESE	5%;1%	CREAM / TOPICAL	RLD, RS	2009-07-31	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N022436-001	XERESE	5%;1%	CREAM / TOPICAL	RLD, RS	2009-07-31	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N022436-001	XERESE	5%;1%	CREAM / TOPICAL	RLD, RS	2009-07-31	`cb3db0bc1861…`

Observed Orange Book patent history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Source SHA-256
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N022436-001	7223387	2022-11-13	U-1006	Drug product	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N022436-001	7223387	2022-11-13	U-1484	Drug product	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N022436-001	7223387	2022-11-13	U-1006	Drug product	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N022436-001	7223387	2022-11-13	U-1484	Drug product	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N022436-001	7223387	2022-11-13	U-1006	Drug product	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N022436-001	7223387	2022-11-13	U-1484	Drug product	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N022436-001	7223387	2022-11-13	U-1006	Drug product	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N022436-001	7223387	2022-11-13	U-1484	Drug product	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N022436-001	7223387	2022-11-13	U-1484	Drug product	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N022436-001	7223387	2022-11-13	U-1006	Drug product	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N022436-001	7223387	2022-11-13	U-1006	Drug product	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N022436-001	7223387	2022-11-13	U-1484	Drug product	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N022436-001	7223387	2022-11-13	U-1006	Drug product	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N022436-001	7223387	2022-11-13	U-1484	Drug product	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N022436-001	7223387	2022-11-13	U-1006	Drug product	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	N022436-001	7223387	2022-11-13	U-1484	Drug product	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N022436-001	7223387	2022-11-13	U-1006	Drug product	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N022436-001	7223387	2022-11-13	U-1484	Drug product	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N022436-001	7223387	2022-11-13	U-1006	Drug product	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N022436-001	7223387	2022-11-13	U-1484	Drug product	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N022436-001	7223387	2022-11-13	U-1006	Drug product	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N022436-001	7223387	2022-11-13	U-1484	Drug product	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N022436-001	7223387	2022-11-13	U-1006	Drug product	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N022436-001	7223387	2022-11-13	U-1484	Drug product	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N022436-001	7223387	2022-11-13	U-1006	Drug product	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N022436-001	7223387	2022-11-13	U-1484	Drug product	`ea99ee380514…`
2022-09-29 23:25 UTC	2022-09	N022436-001	7223387	2022-11-13	U-1006	Drug product	`e64feba35796…`
2022-09-29 23:25 UTC	2022-09	N022436-001	7223387	2022-11-13	U-1484	Drug product	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N022436-001	7223387	2022-11-13	U-1484	Drug product	`cb3db0bc1861…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N022436-001	7223387	2022-11-13	U-1006	Drug product	`cb3db0bc1861…`

Additional Listing Data#

Finished product: Yes
Brand name base: Xerese
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
ACYCLOVIR	50 mg/g
HYDROCORTISONE	10 mg/g

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
X4HES1O11F	Internal UNII lookup
WI4X0X7BPJ	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
998422	Internal RxNorm lookup
998426	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
3b6ac164-0f1e-4f36-94a1-1fdb07d710f5	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
15bd4439-874a-4934-9954-248e5455d460	Product name	1	20260310
9962b773-9f2e-22cc-0032-535e48ac417b	Product name	3	20250724
56bb0587-1bf2-48b2-9d93-fc9f59d1eeb2	Product name	1	20250325
33190c02-82e1-0a4d-d716-9ccd23588463	Product name	5	20250225
c367d1da-5a72-8966-6d11-1eb9a73ae758	Product name	3	20231115
4d56e8eb-d741-d4a5-de3f-2bab1af75a60	Product name	7	20220608
5518bf13-db2f-2e9c-3679-e70ecf03752c	Product name	9	20210614
626d7260-31b5-4412-84fd-579746adb6b3	Product name	1	20210513
27897900-0e40-497b-97e1-88057e68fe6c	Product name	4	20200710
ca834e59-e669-229c-9288-0ccb76dc373e	Product name	9	20200220
d7f95c49-d3e1-4bbc-a389-e9cd73f59a28	Product name	1	20190702
8a011600-5e61-4c59-ab7b-54ab658a3b71	Product name	2	20181127
a919621a-248d-3c7a-1084-9f9ce286fdfd	Product name	2	20181009
e7d5a174-836b-a0af-b014-cb0826c69ddc	Product name	2	20181004
fcce390d-6460-4701-87cf-940d8800a1c3	Product name	2	20180212
fb15b394-3715-4c87-a447-421489aa8739	Product name	3	20170727
bf065fa6-1e3b-e4c3-0bde-2dc842ceeea1	Product name	2	20150218
02657a3f-1489-66ea-f740-5ab9524e57d7	Product name	1	20140508
26f3d783-2cc1-4327-e77d-71804cf675a2	Product name	1	20140508
36fdc54c-bbeb-981e-8a53-4d768e283892	Product name	1	20140508
58f3f9b7-3b9b-a9c1-1c9f-18ac777192b8	Product name	1	20140508
61e59a42-186b-9f4b-aec3-fb49a6debc31	Product name	1	20140508
705740e1-dee5-2610-c5a3-4c59cd9d62af	Product name	1	20140508
7bdc4804-3832-c0df-e519-72b6d47c9792	Product name	1	20140508
a7051cba-790b-a699-81f8-dbbbdbd9b5ac	Product name	1	20140508
abaf203f-619e-f265-559f-8c81af5cb1c2	Product name	1	20140508
acc4d8bb-0e29-e9f8-65f8-31e94184a9c0	Product name	1	20140508
b045ad64-0f28-9a02-2f9b-b34d94fb2278	Product name	1	20140508
bfd28ffb-d550-3fe9-f65b-10bcb7f971fd	Product name	1	20140508
da108d9e-edc8-17a3-8c28-3251c6a8accc	Product name	1	20140508
fe21f3fd-a378-0654-1972-db3c3b64470e	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
0187-5104-01	Xerese	1 in 1 CARTON	CREAM	1	7
0187-5104-01	Xerese	5 g in 1 TUBE	CREAM	5	7
0187-5104-02	Xerese	0.5 g in 1 PACKET	CREAM	0.5	7
0187-5104-02	Xerese	20 in 1 CARTON	CREAM	20	7

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0187-5104-01	GM - Gram	0187-5104	3be8e2a1-6d8f-41e1-a6bd-2d55b60abac7	1	2013-02-13

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
ACYCLOVIR	ACTIVE INGREDIENT	X4HES1O11F	XERESE (ACYCLOVIR AND HYDROCORTISONE) CREAM [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]	4
HYDROCORTISONE	ACTIVE INGREDIENT	WI4X0X7BPJ	XERESE (ACYCLOVIR AND HYDROCORTISONE) CREAM [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]	4
ACYCLOVIR	ACTIVE MOIETY	X4HES1O11F	XERESE (ACYCLOVIR AND HYDROCORTISONE) CREAM [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]	4
HYDROCORTISONE	ACTIVE MOIETY	WI4X0X7BPJ	XERESE (ACYCLOVIR AND HYDROCORTISONE) CREAM [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]	4
cetostearyl alcohol	INACTIVE INGREDIENT	2DMT128M1S	XERESE (ACYCLOVIR AND HYDROCORTISONE) CREAM [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]	4
citric acid monohydrate	INACTIVE INGREDIENT	2968PHW8QP	XERESE (ACYCLOVIR AND HYDROCORTISONE) CREAM [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]	4
isopropyl myristate	INACTIVE INGREDIENT	0RE8K4LNJS	XERESE (ACYCLOVIR AND HYDROCORTISONE) CREAM [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]	4
mineral oil	INACTIVE INGREDIENT	T5L8T28FGP	XERESE (ACYCLOVIR AND HYDROCORTISONE) CREAM [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]	4
petrolatum	INACTIVE INGREDIENT	4T6H12BN9U	XERESE (ACYCLOVIR AND HYDROCORTISONE) CREAM [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]	4
Poloxamer 188	INACTIVE INGREDIENT	LQA7B6G8JG	XERESE (ACYCLOVIR AND HYDROCORTISONE) CREAM [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]	4
propylene glycol	INACTIVE INGREDIENT	6DC9Q167V3	XERESE (ACYCLOVIR AND HYDROCORTISONE) CREAM [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]	4
sodium hydroxide	INACTIVE INGREDIENT	55X04QC32I	XERESE (ACYCLOVIR AND HYDROCORTISONE) CREAM [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]	4
sodium lauryl sulfate	INACTIVE INGREDIENT	368GB5141J	XERESE (ACYCLOVIR AND HYDROCORTISONE) CREAM [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]	4
water	INACTIVE INGREDIENT	059QF0KO0R	XERESE (ACYCLOVIR AND HYDROCORTISONE) CREAM [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]	4

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0187-5104	XERESE (ACYCLOVIR AND HYDROCORTISONE) CREAM [BAUSCH HEALTH US LLC]	7	Current NDC, Legacy NDC, 4 package rows	20200905_3b6ac164-0f1e-4f36-94a1-1fdb07d710f5.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Xerese	ACYCLOVIR AND HYDROCORTISONE	Bausch Health US LLC	3b6ac164-0f1e-4f36-94a1-1fdb07d710f5	2020-08-03	Warnings, Adverse reactions	Exact identifier application applno (NDA): 022436 application number: NDA022436 ndc (product): 0187-5104

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
X4HES1O11F	ACYCLOVIR	59277-89-3	ACYCLOVIR
WI4X0X7BPJ	HYDROCORTISONE	50-23-7	HYDROCORTISONE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
998422	acyclovir 5 % / hydrocortisone 1 % Topical Cream	PSN	3b6ac164-0f1e-4f36-94a1-1fdb07d710f5	7
998426	Xerese (acyclovir 5 % / hydrocortisone 1 % ) Topical Cream	PSN	3b6ac164-0f1e-4f36-94a1-1fdb07d710f5	7
998426	acyclovir 50 MG/ML / hydrocortisone 10 MG/ML Topical Cream [Xerese]	SBD	3b6ac164-0f1e-4f36-94a1-1fdb07d710f5	7
998422	acyclovir 50 MG/ML / hydrocortisone 10 MG/ML Topical Cream	SCD	3b6ac164-0f1e-4f36-94a1-1fdb07d710f5	7
998422	acyclovir 5 % / hydrocortisone 1 % Topical Cream	SY	3b6ac164-0f1e-4f36-94a1-1fdb07d710f5	7
998422	acycycloguanosine 50 MG/ML / Hydrocortisone 10 MG/ML Topical Cream	SY	3b6ac164-0f1e-4f36-94a1-1fdb07d710f5	7
998426	acycycloguanosine 50 MG/ML / Hydrocortisone 10 MG/ML Topical Cream [Xerese]	SY	3b6ac164-0f1e-4f36-94a1-1fdb07d710f5	7
998426	Xerese (acyclovir 5 % / hydrocortisone 1 % ) Topical Cream	SY	3b6ac164-0f1e-4f36-94a1-1fdb07d710f5	7

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
0187-5104-01	00187510401	1 TUBE in 1 CARTON (0187-5104-01) / 5 g in 1 TUBE	1 tube	2009-07-31	0000-00-00	No	No	Current
0187-5104-02	00187510402	0.5 g in 1 PACKET	0.5 g					Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Xerese	Bausch Health US LLC \| Contract Pharmaceuticals Limited Canada \| Bausch Health Companies Inc.	2020-08-03	HUMAN PRESCRIPTION DRUG LABEL	7